Wait a second!
More handpicked essays just for you.
More handpicked essays just for you.
Don’t take our word for it - see why 10 million students trust us with their essay needs.
Recommended: Sepsis
Sepsis is a potentially fatal medical condition where the blood is overwhelmed by the presence of bacteria; activating the immune response and potentially causing organ dysfunction due to the disruption of homeostasis, tissue perfusion and limited oxygen supply. Systemic inflammatory response syndrome can be a key to the recognition of the illness. This condition can be treated with antibiotics intravenously or by draining the infected fluid. However, treating the infection with appropriate anti-microbial medication does not always cure the illness. Understanding the activation of inflammation, coagulation and fibrinolysis in the pathophysiology of sepsis, has allowed further research and development of therapeutic agents in its clinical treatment (Della, 2012).
In response to pathogens infecting the body, leukocytes release cytokines, some examples are interleukin-1, 6 and tumour necrosis factor α (Bernard, 2001). These can cause extensive activation of coagulation and decreased fibrinolysis; thus the equilibrium of the body normally regulated by homeostasis is altered (van Deventer, 1990). Coagulation is activated by stimulating factors leading to the generation of thrombin. Thrombin can stimulate inflammatory pathways, thus reducing fibrinolysis further. However, the activation is reduced in sepsis. One anticoagulant system that regulates thrombin formation is Protein C; which is converted to its activated form by thrombin. Thus, Activated Protein C (APC) alters the coagulation system, and in turn prevents thrombosis and promotes fibrinolysis (Esmon, 1989).
Protein C is a naturally occurring anti-coagulant with key pathways that are beneficial in the treatment of sepsis; such as the cytoprotective mechanisms which include ant...
... middle of paper ...
...cts of recombinant human activated protein C in a ewe model of septic shock. Crit Care Med. ;35(11):2594-600.
van Deventer SJH, Bluller HR, ten Cate JW, Aarden LA, Hack CE, Sturk A. (1990) Experimental endotoxemia in humans: analysis of cytokine release and coagulation, fibrinolytic, and complement pathways. Blood. ;76:2520–2528
Hancock WW, Bach FH. (1997)Immunobiology and therapeutic applications of protein C/protein S/thrombomodulin in human and experimental allo-transplantation and xenotransplantation. Trends Cardiovasc Med. ;7:174–183.
Neyrinck AP, Liu KD, Howard JP, Matthay MA. (2009) Protective mechanisms of activated protein C in severe inflammatory disorders. Br J Pharmacol. ;158(4): 1034–1047
Bernard GR, Vincent JL, Laterre PF, et al. (2001) Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med. ;344:699–709.
However with septic shock the symptoms may be worse as the patient may experience tachyeordia and tachypnae, leucocytosis which is a high count of white blood cells, change in metal state for example confusion and hyperglycaemia which is a deficiency of glucose in the bloodstream. The diagnosis for sepsis and septic shock involve using blood cultures which is where bacteria is detected in blood which may have spread from a different part of the body. Blood cultures are taken mostly to be done on new-borns and young children who have the symptoms of sepsis. If the blood culture tests positive there is a bacterial or fungal infection which needs to be treated immediately as it is life-threatening. Also cytokines are used as they can destroy the infection however there is a problem with this diagnosis as excessive production can cause tissue and organ
Unfortunately, infection places people in the hospital and infection is developed in the hospital. Two ways to contract sepsis are through hospital-caused infection, like in Amy Widener’s case, and through an infection caused by outside sources, for example a urinary tract infection in an elderly person. Everyone is capable of getting sepsis however cases appear most often in children under one year of age and in elderly older than sixty-five years. This is due to the body’s immune system being weaker in these demographics than in a person that has a built-up and strong immune system (“Sepsis Questions and Answers”). Sepsis occurs because of infection so the immune system plays a large role in the body’s defense mechanism. When people with already compromised immune systems develop an infection or are in an environment that infection is likely to occur, for example an unsanitary procedure in a hospital, then the body’s chances of being able to fight the infection off are greatly
Antimicrobial therapy is the cornerstone sepsis treatment, and the therapeutic goal should be centered around administration of effective IV antibiotics within 60 minutes of septic shock or severe sepsis (without shock) recognition. The initial antimicrobial therapy should be empiric and focused on having activity against all expected pathogens (bacterial, fungal, viral), based on each individual patient situation. Daily reassessment of antimicrobial therapy should be performed, with de escalation in mind; procalcitonin levels can be of use to direct discontinuation in patients with no evidence of infection following initial septic
Daniels (2011) said that sepsis is one of the leading causes of death in hospital patient worldwide and severe sepsis causes around 37,000 deaths in the UK every year. Czura (2011) has defined it as a life-threatening condition that arises when the body’s response to infection injures its own tissues and organs and sepsis can be present in any patient and in any clinical setting. Based on the learner’s reading, she became aware of the importance of identifying the early inflammatory markers such as temperature less than 36 degrees or more than 38.3 degrees, heart rate greater than 90 beats per minute (bpm), respiratory rate greater than 20 breaths/minute, altered mental state, white cell count lesser than 4g/l or greater than 12g/l and blood glucose greater than 7.7 millimoles for non-diabetic patients. Presence of any two of these will follow further test and if sepsis is indicated then commence the sepsis six care bundle within the hour, contact the doctor and critical care outreach team. The sepsis six care bundle which was developed by Daniels et al (2010) has shown to improve delivery of reliable care across a range of clinical settings which is now used in many UK
In some individuals with severe hemophilia, the factor VIII replacement therapy is identified as a foreign substance by their immune system. If this happens, their immune system will make antibodies against factor VIII. These antibodies will inhibit the ability of the factor to work in the clotting process. The higher the antibody or inhibitor level, the more factor VIII replacement therapy it takes to overcome the inhibition and produce clotting. This can complicate the treatment of a bleed. The good news is that there are different types of therapies available to successfully treat most individuals who develop inhibitors.
“Immune Response: MedlinePlus Medical Encyclopedia.” National Library of Medicine - National Institutes of Health. Web. 18 Dec. 2011. .
Many great historical figures of the scientific community have written on the subject of the same perplexing disease over the centuries (Angus, van der Poll, Finfer, Vincent 2013). Sepsis has been given many names, origins, and etiologies. In the 4th century, Hippocrates declared the disease the cause of organic decomposition, wound festering, and swamp gas (Angus et al. 2013). During the 19th century, Louis Pasteur theorized the disease was the outcome of a pathogenic microorganism in the bloodstream, which resulted in a body-wide infection (Angus et al. 2013). In the 21st century, the medical community made a breakthrough with the discovery of the disease’s link to the inflammatory response system and devised a plan of action to combat the high mortality rates among those infected (Angus et al. 2013). According to Hotchkiss, Monneret, & Payen (2013) the effects of sepsis are well documented, while the molecular processes it utilizes are still being explored; however, new studies are helping to expand our understanding of the centuries old disease.
Even with the ICU, the rates of in-hospital deaths from septic shock were usually more than 80%. This was just 30 years ago. Today the mortality rate is closer to 20 to 30% now. The nurses have advanced in training/technology, better monitoring, and immediate therapy to treat the infection and support failing organs (Angus, 2014). Since the death rates are decreasing, the focus is more on the recovery of the sepsis survivor. A patient who survives to hospital discharge after the diagnosis of sepsis, remains at an increased risk for death in the next following months and years. Those who are sepsis survivors often have impaired neurocognitive or physical functioning. They also have mood disorders, and a decreased quality of life (Angus, 2013). There are resources now available for pre-hospital and community settings. This will further improve timeliness of diagnosis and treatment (McClelland,
In patients infected with K. pneumonia, inflammatory mechanisms can cause tissue damage that is related with a release of “alarm proteins” (Achouiti, 2012). These alarm proteins are known as the Damage Associated Molecular Patters (DAMPs) and are seen in neutrophils where they potentially affect up to 45 percent of the cytoplasmic protein (Achouiti, 2012). This is harmful because it inhibits the body’s ability to fight the infection, as neutrophils are the body’s natural immunity defense.
Sepsis is defined as an exaggerated, overwhelming and uncontrolled systemic inflammatory response to an initially localised infection or tissue injury, which may lead to severe sepsis and septic shock if left untreated (Daniels, 2009; Robson & Daniels, 2013; Dellinger et al, 2013; Perman, Goyal & Gaieski, 2012; Vanzant & Schmelzer, 2011). Septic shock can be classified by acute circulatory failure as a result of massive vasodilation, increased capillary permeability and decreased vascular resistance in the body, causing refractory hypotension despite adequate fluid resuscitation. This leads to irreversible tissue ischaemia, end organ failure and ultimately, death (McClelland & Moxon, 2014; Sagy, Al-Qaqaa & Kim, 2013, Dellinger et al, 2013).
Sepsis has gained much focus as a major global health problem. Since 2003, an international team of experts came together to form the Surviving Sepsis Campaign (SSC), in the attempts to combat an effectively treat sepsis. Although, diagnostics and protocols have been developed to identify high risk patients, the need for human clinical assessment is still necessary to ensure a proper diagnosis is made and appropriate treatment is initiated in a timely manner. The use of a highly efficient and experienced team, such as, the electronic Intensive Care unit (eICU) could close the gap from diagnosis to treatment.
Sepsis is defined as a systemic inflammatory response caused by an infective process such as viral, bacterial or fungal (Holling, 2011). Assessment on a patient and starting treatment for sepsis is based on identifying several factors including the infective source, antibiotic administration and fluid replacement (Bailey, 2013). Because time is critical any delay in identifying patients with sepsis will have a negatively affect the patients’ outcome. Many studies have concluded every hour in delay of treatment mortality is increased by 7% (Bailey, 2013). Within this assignment I will briefly discuss the previous practice and the recent practice including the study based on sepsis. I will show what enabled practice to change and I will use the two comparisons of current practice and best practice.
“ Sepsis” according to the International Surviving Sepsis Campaign, is defined as the presence of infection together with systemic manifestations of infection (Dellinger et al., 2013) In todays modern society sepsis still accounts for 15% of maternal deaths a year worldwide (Dolea & Stein, 2003). Despite medical advances, aseptic technique, and antibiotic use, sepsis is the most common cause of direct maternal death in the UK. According to the CMACE report the maternal mortality rate increased from 0.85 deaths per 100,000 maternities in 2003–05 to 1.13 deaths in 2006–08 (Harper, 2011). Puerperal sepsis has a long history within obstetrics and midwifery, and yet despite this knowledge it has become, yet again, the leading cause of direct maternal death. Therefore due to the increased maternal mortality, I have chosen to focus on the care of a woman within ...
Immediately after wounding, the first phase of hemostatsis sets in motion with vascular constriction which restricts the blood flow in the blood vessels followed by the platelets plug formation which creates a temporary blockage of blood flow and then coagulation takes place with fibrin clot formation. The clot and surrounding tissue release pro-inflammatory growth factors and cytokines such as transforming growth factor (TGF)-13, platelet-derived growth factor (PDGF), fibroblast growth factor (FGF) and epidermal growth factor (EGF).
The white blood cells destroy any unfamiliar pathogens in the bloodstream and can cause inflammation. Therefore, the inflammation causes a surplus of white blood cells to clot the wound for healing.